Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes

This study has been completed.
Sponsor:
Information provided by:
Steno Diabetes Center
ClinicalTrials.gov Identifier:
NCT00118963
First received: July 1, 2005
Last updated: December 5, 2008
Last verified: December 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2006
  Primary Completion Date: February 2006 (Final data collection date for primary outcome measure)
No publications provided by Steno Diabetes Center

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):